Semaglutide is a prescription medication approved by the FDA to help manage type 2 diabetes (Ozempic) and to support long-term weight loss (Wegovy)
The only sign is reduced efficacy (weight loss stalls, appetite suppression weakens)
Jump to: Obesity and mental health | Take home message | Second Natures medication programmes Based on analyses of real-world data investigating the link between Wegovy and mental health, Wegovy doesnt appear to cause an increase in the risk of developing anxiety, depression, suicidal ideation, or other mental health conditions
This information could potentially provide critical evidence for guidelines to be created
Gallstones are themselves a risk factor for acute pancreatitis
You may have a case if you: developed a thyroid tumor were diagnosed with medullary thyroid carcinoma developed suspicious nodules needed surgery or biopsy were not properly warned suffered other severe GLP-1 complications Compensation may include: medical costs surgery and treatment long-term cancer care lost income pain and suffering reduced quality of life See if you qualify: GLP-1 Drug Lawsuits Ozempic Lawsuit Related Information Long-Term GLP-1 Risks Severe GLP-1 Reactions Common GLP-1 Side Effects Ozempic Side Effects Mounjaro Side Effects Wegovy Side Effects The FDA Black Box Warning for GLP-1 drugs signals the potential risk of thyroid C-cell tumors, including Medullary Thyroid Carcinoma
